Interim Condensed Consolidated Statements of Income (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Revenues:
Net patient revenues	$ 215,351,000	$ 207,772,000	$ 641,845,000	$ 613,173,000
Other revenues	10,035,000	10,451,000	30,850,000	32,136,000
Net operating revenues	225,386,000	218,223,000	672,695,000	645,309,000
Cost and Expenses:
Salaries, wages and benefits	135,136,000	128,938,000	392,766,000	374,277,000
Other operating	56,616,000	55,365,000	173,830,000	166,803,000
Facility rent	10,006,000	9,913,000	29,972,000	29,712,000
Depreciation and amortization	9,273,000	8,639,000	27,442,000	25,144,000
Interest	594,000	632,000	1,782,000	1,566,000
Total costs and expenses	211,625,000	203,487,000	625,792,000	597,502,000
Income Before Non–Operating Income	13,761,000	14,736,000	46,903,000	47,807,000
Non–Operating Income	4,550,000	3,937,000	12,902,000	12,790,000
Income Before Income Taxes	18,311,000	18,673,000	59,805,000	60,597,000
Income Tax Provision	(5,744,000)	(5,844,000)	(21,638,000)	(22,028,000)
Net Income	12,567,000	12,829,000	38,167,000	38,569,000
Dividends to Preferred Stockholders	(2,152,000)	(2,167,000)	(6,487,000)	(6,502,000)
Net Income Available to Common Stockholders	$ 10,415,000	$ 10,662,000	$ 31,680,000	$ 32,067,000
Earnings Per Common Share:
Basic (in dollars per share)	$ 0.75	$ 0.77	$ 2.30	$ 2.32
Diluted (in dollars per share)	$ 0.72	$ 0.75	$ 2.21	$ 2.25
Weighted Average Common Shares Outstanding:
Basic (in shares)	13,801,245	13,805,430	13,778,705	13,838,891
Diluted (in shares)	14,422,660	14,236,512	14,365,251	14,230,031
Dividends declared to common stockholders per share (in dollars per share)	$ 0.40	$ 0.34	$ 1.14	$ 1